Sunway Healthcare FY2025 Net Profit Eases To RM252 Mln, But Revenue Rises To RM2.2 Bln
KUALA LUMPUR, March 16 (Bernama) -- Sunway Healthcare Holdings Bhd's (SHH) net profit fell to RM252.21 million for the financial year ended Dec 31, 2025 (FY2025) from RM257.50 million a year earlier.
However, the group said it recorded an increase in earnings before interest, taxes, depreciation, and amortisation (EBITDA) of RM510.4 million for FY2025 compared to RM469.7 million in FY2024, mainly due to higher operating performance in the hospital operations segment.
SHH's revenue rose to RM2.20 billion compared with RM1.85 billion in FY2024, supported by the higher hospital operations segment revenue, which increased 19 per cent compared to the previous year. This was driven by stronger growth across existing hospitals and contributions from newly operational hospitals that were not in operation during the prior year.
"Foreign patient revenue also increased to RM304.7 million from RM220.4 million, representing a significant year-on-year growth of 38 per cent, which was driven by patients from Indonesia, China and Cambodia," it said in a stock exchange filing.
The group said its overall bed occupancy rate for the FY2025 was 69 per cent, compared to 79 per cent in the previous year. "Excluding newly opened hospitals, bed occupancy rate for the current financial year stood at 73 per cent, demonstrating healthy bed utilisation across established hospitals," it added.
For the fourth quarter (4Q) of FY2025, SHH posted a higher net profit of RM112.38 million compared with RM78.40 million in the same period a year ago, while revenue increased to RM614.64 million from RM506.73 million recorded in 4Q FY2024.
SHH president and non-independent executive director, Datuk Lau Beng Long, said in a separate statement that the company's performance in FY2025 demonstrated the strength of the group's integrated healthcare ecosystem and the sustained demand for high-quality private healthcare services in Malaysia.
"Even with FY2025 marking a year of rapid expansion with the opening of Sunway Medical Centre (SMC) Damansara and SMC Ipoh, the group delivered strong revenue growth by maintaining our commitment to clinical excellence and expanding our share in the medical tourism market," he noted.
He said the group remains focused on deepening its clinical capabilities, expanding and optimising capacity across its network, and leveraging digital and data-driven initiatives to enhance operational efficiency and patient experience.
On its outlook, SHH said that it remains cautiously optimistic for FY2026 “despite ongoing payor pressures, supported by resilient demand for private healthcare services, progressive stabilisation of newly operational hospitals, and continued focus on asset optimisation and operational efficiency.”
"The Ministry of Health’s decision to defer the implementation of the Diagnosis-Related Group system to 2027 provides greater clarity and allows for a more orderly transition while the group continues to enhance system readiness and organisational capability in clinical coding and documentation," it added.
-- BERNAMA